Baicalein significantly protects human retinal pigment epithelium cells against H2O2-induced oxidative stress by scavenging reactive oxygen species and downregulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 5, 2010, Pages 421-429

  Liu, Jorn Hon ^a,b   Wann, Hsiung ^a,b   Chen, Mi Mi ^a   Pan, Wynn H T ^b   Chen, Yei Ching ^a   Liu, Chi Ming ^a   Yeh, Ming Yang ^a   Tsai, Shen Kou ^a   Young, Mason Shing ^a   Chuang, Hui Yen ^a   Chao, Fang Ping ^a   Chao, Hsiao Ming ^a,b  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; DICHLOROFLUORESCEIN; GELATINASE B; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; UPREGULATION;

ANTIOXIDANTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLAVANONES; HUMANS; HYDROGEN PEROXIDE; MACULAR DEGENERATION; MATRIX METALLOPROTEINASE 9; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL PIGMENT EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957956546     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0063     Document Type: Article

References (40)

1. Klein, R., Klein, B.E., Jensen, S.C., and Meuer, S.M. The five-year incidence and progression of age-related maculopathy. Beaver Dam Eye Study. Ophthalmology 104:7-21, 1997.
2. Klein, R., Klein, B.E., and Linton K.L. Prevalence of agerelated maculopathy. Beaver Dam Eye Study. Ophthalmology 99:933-943, 1992.
3. Kaiser, P.K. Verteporfin photodynamic therapy and antiangiogenic drugs: potential for combination therapy in exudative age-related macular degeneration. Curr. Med. Res. Opin. 23:477-487, 2007.
4. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 36:1271-1279, 1995.
5. Schipper, H.M. Brain iron deposition and the free radicalmitochondrial theory of ageing. Ageing Res. Rev. 3:265-301, 2004.
6. LeVine, S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760:298-303, 1997.
7. Kaur, D., and Andersen, J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res. Rev. 3:327-343, 2004.
8. Zarbin, M.A. Current concepts in the pathogenesis of agerelated macular degeneration. Arch. Ophthalmol. 122:598-614, 2004.
9. Tsai, D.C., Charng, M.J., Lee, F.L., Hsu, W.M., and Chen, S.J. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica 220:246-251, 2006.
10. Hubschman, J.P., Reddy, S., and Schwartz, S.D. Age-related macular degeneration: current treatments. Clin. Ophthalmol. 3:155-166, 2009.
11. Spinale, F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 87:1285-1342, 2007.
12. Chau, K.Y., Sivaprasad, S., Patel, N., et al. Plasma levels of matrix metalloproteinase-2 and-9 (MMP-2 and MMP- 9) in age-related macular degeneration. Eye 22:855-859, 2008.
13. Chang, W.T., Shao, Z.H., Yin, J.J., et al. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur. J. Pharmacol. 566:58-66, 2007.
14. Wartenberg, M., Budde, P., De Marees, M., et al. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine. Lab. Invest. 83:87-98, 2003.
15. Dunn, K.C., Aotaki-Keen, A.E., Putkey, F.R., and Hjelmland, L.M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62:155-169, 1996.
16. 2-induced oxidative stress in human retinal pigment epithelium cells. J. Ocul. Pharmacol. Ther. 26:249-257, 2010.
17. Cazevieille, C., Safa, R., and Osborne, N.N. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res. 768:120-124, 1997.
18. Patil, A.J., Gramajo, A.L., and Sharma, A. Differential effects of nicotine on retinal and vascular cells in vitro. Toxicology 259:69-76, 2009.
19. LeBel, C.P., Ali, S.F., McKee, M., and Bondy, S.C. Organometal- induced increases in oxygen reactive species: the potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 104:17-24, 1990.
20. Smith, P.K., Krohn, R.I., Hermanson, G.T., et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85, 1985.
21. Engvall, E., and Perlmann, P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874, 1971.
22. Kuenz, B., Lutterotti, A., Ehling, R., et al. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 3:e2559, 2008.
23. Halliwell, B., Clement, M.V., and Long, L.H. Hydrogen peroxide in the human body. FEBS Lett. 486:10-13, 2000.
24. Takanashi, T., Ogura, Y., Taguchi, H., Hashizoe, M., and Honda, Y. Fluorophotometric quantitation of oxidative stress in the retina in vivo. Invest. Ophthalmol. Vis. Sci. 38:2721-2728, 1997.
25. Bailey, T.A., Kanuga, N., Romero, I.A., et al. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 45:675-684, 2004.
26. Kim, M.H., Chung, J., Yang, J.W., et al. Hydrogen peroxideinduced cell death in a human retinal pigment epithelial cell line, ARPE-19. Korean J. Ophthalmol. 17:19-28, 2003.
27. 2 as a trigger and NF-kappaB as a signal transducer. Thromb. Haemost. 90:528-537, 2003.
28. van Leeuwen, R., Boekhoorn, S., Vingerling, J.R., et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294:3101-3107, 2005.
29. Seddon, J.M. Multivitamin-multimineral supplements and eye disease age-related macular degeneration and cataract. Am. J. Clin. Nutr. 85:304S-307S, 2007.
30. Remacle, J., Michiels, C., and Raes, M. The importance of antioxidant enzymes in cellular aging and degeneration. EXS 62:99-108, 1992.
31. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D.A. Review: Alzheimer's amyloid [beta]-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130:184-208, 2000.
32. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., and Offen, D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54:271-284, 2002.
33. Chao, H.M., Chidlow, G., Melena, J., Wood, J.P.M., and Osborne, N.N. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina. Brain Res. 877:47-57, 2000.
34. Chao, H.M., Chen, Y.H., Liu, J.H., et al. Iron-generated hydroxyl radicals kill retinal cells in vivo: effect of ferulic acid. Hum. Exp. Toxicol. 27:327-339, 2008.
35. Miceli, M.V., Liles, M.R., and Newsome, D.A. Evaluation of oxidative processes in human retinal pigment epithelial cells associated with retinal outer segment phagocytosis. Exp. Cell Res. 214:242-249, 1994.
36. Nie, D., Krishnamoorthy, S., Jin, R., et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J. Biol. Chem. 28:18601-18609, 2006.
37. Yang, L.P., Sun, H.L., Wu, L.M., et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 50:2319-2327, 2009.
38. Hanneken, A., Lin, F.F., Johnson, J., and Maher, P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest. Ophthalmol. Vis. Sci. 47:3164-3177, 2006.
39. Chen, S.F., Hsu, C.W., Huang, W.H., and Wang, J.Y. Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br. J. Pharmacol. 155:1279-1296, 2008.
40. Jung, S.H., Kang, K.D., Ji, D., et al. The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochem. Int. 53:325-337, 2008.